Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.36 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL27199832 | 1.00 | BLM (0.47) | BLMKDM4EALOX15CCR5PKM | |
| Cadaverine Tartrate SCHEMBL30866561 | 0.93 | BLM (0.56) | BLMKDM4EALOX15CCR5PKM | |
| Acetic Acid SCHEMBL27199919 | 0.90 | KDM4E (0.43) | BLMKDM4EALOX15CCR5CHRNB2 | |
| Malic Acid SCHEMBL27199905 | 0.88 | BLM (0.43) | BLMKDM4EALOX15CCR5PKM | |
| Malic Acid SCHEMBL27199912 | 0.88 | BLM (0.43) | BLMKDM4EALOX15CCR5PKM | |
| SCHEMBL27199834 | 0.87 | CHRNA7 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL27199831 | 0.87 | CHRNA7 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL30866532 | 0.87 | CHRNA7 (0.45) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Benzoic Acid SCHEMBL27199942 | 0.84 | CHRNB2 (0.43) | BLMKDM4EALOX15CCR5PKM | |
| Levulinic Acid SCHEMBL27199888 | 0.82 | CCR5 (0.38) | BLMKDM4EALOX15CCR5CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | disclosed |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | disclosed |
| WO-2024155297-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | WO | disclosed |
| US-20240246930-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | US | disclosed |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2024-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246930-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | SRM, SCLY, SMOX | BLM 3053/4885KDM4E 812/4885ALOX15 4144/4885 |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | BLM 3053/4885KDM4E 812/4885ALOX15 4144/4885 |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | BLM 1891/4885KDM4E 2277/4885ALOX15 712/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | BLM 3053/4885KDM4E 812/4885ALOX15 4144/4885 |
| US-12358889-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | BLM 3053/4885KDM4E 812/4885ALOX15 4144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.